An Automated Scalable Chemoproteomics Workflow that Recovers Known Serine Hydrolase Target Profiles of Clinically Used Drugs
ACS Chemical Biology · 2026
DOI: 10.1021/acschembio.6c00557 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Chemical Biology, 2026. Verfasst von Franciscus H G Ter Brake und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular Physiology, Leiden University, Leiden2300 RA, The Netherlands. Hauptthemen laut MEDLINE: Proteomics, Hydrolases. Die Arbeit nennt 72 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Oncode Institute, Oncode Accelerator.
Abstract (Originalsprache)
Activity-based protein profiling has established itself as a powerful technology with demonstrated use in on- and off-target profiling. However, determining the off-target profile of many drugs using the unbiased mass spectrometry-based chemoproteomics approach remains time- and cost-intensive. In this study, we implemented an SP3-based, high-throughput, plate-based chemoproteomic workflow compatible with liquid-handling robotics. We then profiled a library of 40 marketed drugs targeting the serine hydrolases or containing potentially reactive electrophiles against the human serine hydrolase proteome in HT29 cell lysate. We included two additional well-studied literature compounds as controls to benchmark our workflow. Our results validated 16 out of 20 intended human targets and found 5 previously described off-targets for the compounds tested. Additionally, we discovered six unknown off-targets that could warrant future follow-up research. In all, our approach demonstrates how automated chemoproteomics can be used to accelerate the identification of clinically relevant off-targets, providing a scalable blueprint for rational drug repurposing.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Molecular Physiology, Leiden University, Leiden2300 RA, The Netherlands.
- Oncode Institute, Utrecht3521 AL, The Netherlands.
ORCID-Profile: Mario van der Stelt, Antonius P A Janssen
Förderung
- Oncode Institute
- Oncode Accelerator
Zitieren
APA
Ter Brake, F. H. G., Gagestein, B., van der Stelt, M., & Janssen, A. P. A. (2026). An Automated Scalable Chemoproteomics Workflow that Recovers Known Serine Hydrolase Target Profiles of Clinically Used Drugs. ACS Chemical Biology. https://doi.org/10.1021/acschembio.6c00557
Vancouver
Ter Brake FHG, Gagestein B, van der Stelt M, Janssen APA. An Automated Scalable Chemoproteomics Workflow that Recovers Known Serine Hydrolase Target Profiles of Clinically Used Drugs. ACS Chemical Biology. 2026. doi:10.1021/acschembio.6c00557
BibTeX
@article{TerBrake2026,
author = {Ter Brake, Franciscus H G and Gagestein, Berend and van der Stelt, Mario and Janssen, Antonius P A},
title = {An Automated Scalable Chemoproteomics Workflow that Recovers Known Serine Hydrolase Target Profiles of Clinically Used Drugs},
journal = {ACS Chemical Biology},
year = {2026},
doi = {10.1021/acschembio.6c00557}
}
EUVIMED